Joel Greenblatt fit · Magic Formula — high ROIC + cheap EV/EBIT
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
47/100
DMixed signals
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to GYRE
EBIT/EV yield ≥ 10%
key1.7%
ROIC ≥ 25%
key11.7%
EV/EBIT ≤ 12
57.2x
Gross margin ≥ 30%
95.5%
How GYRE Scores on Other Strategies
Live Financial Snapshot
Market cap
$731.67M
P/E (TTM)
55.7x
ROIC (TTM)
11.69%
Gross margin
95.48%
Frequently Asked Questions
What is GYRE's Joel Greenblatt fit score?
GYRE scores 47/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own GYRE?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends GYRE.
How often is this score updated?
GYRE's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends GYRE.